TrialAnnals of surgical oncology2025

Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205).

Masayuki Shinkai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.